Molecular Technologies Laboratories LLC
Columbus, OH Doing business as Infinixbio
- UEI
- NKKEDAM7XLM7
- CAGE
- 8ENN6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1507 Chambers Rd #305, Columbus, OH 43212, USA
- Website
- infinixbio.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a growth hormone receptor antagonist for the delay or prevention of adrd | National Institute on Aging (NIH) | $1,495,109 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Research Institute At Nationwide Children's Hospital | HT94252510193 | $175,000 |
Quick answers
Is Molecular Technologies Laboratories LLC registered in SAM.gov?
Yes. Molecular Technologies Laboratories LLC's SAM.gov registration is active through June 24, 2027.
What is Molecular Technologies Laboratories LLC's most recent federal award?
Molecular Technologies Laboratories LLC's most recent federal grant award is Development of a growth hormone receptor antagonist for the delay or prevention of adrd (R41AG085916), from National Institute on Aging (NIH), on February 15, 2024.
On GovTribe
See Molecular Technologies Laboratories LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors